Mark_Fishman

Mark Fishman

Mark Fishman

American cardiologist

Mark Fishman is an American cardiologist, a professor in the Harvard Department of Stem Cell and Regenerative Biology and Chief of the Pathways Clinical Service service at the Massachusetts General Hospital for patients with complex medical disorders.[1] A researcher and clinician in cardiology, he is the previous president of the Novartis Institutes for BioMedical Research (NIBR),[2] the main research arm of Novartis Pharmaceuticals.[3]

Quick Facts Citizenship, Alma mater ...

Fishman was appointed president of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort.[4] He is the author of over 100 publications[5] and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.[6][7][8]

Education

Career

He was previously a professor of medicine at Harvard Medical School, chief of cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine.[9]

After being the head of Novartis for 13 years, he decided to retire in 2016[10] and became professor at Harvard and Chief at MGH[1]


References

  1. [1]
    "Mark C. Fishman, M.D." Harvard Department Of Stem Cell And Regenerative Biology. Retrieved Oct 19, 2022.
  2. [2]
    "Novartis People". Archived from the original on 2015-06-01. Retrieved 2009-10-20.
  3. [3]
    "Novartis Corporate Fact Sheet". Archived from the original on 2011-02-02. Retrieved 2009-10-20.
  4. [4]
    "PRdomain.com | Novartis| Novartis steps up US research investment, opening Cambridge, Massachusetts Biomedical Research Center". Archived from the original on 2011-06-16. Retrieved 2009-10-20.
  5. [5]
    http://www.pubmed.gov 183 results as of 20 Oct 2009
  6. [6]
    Barut, Bruce A.; Zon, Leonard I. (2000). "Realizing the potential of zebrafish as a model for human disease". Physiological Genomics. 2 (2): 49–51. doi:10.1152/physiolgenomics.2000.2.2.49. PMID 11015581. S2CID 12510521.
  7. [7]
    "Fishman profile, Forbes.com". Jan 2002. Archived from the original on 2009-04-03.
  8. [8]
    "Fishman biographical sketch" (PDF). Archived from the original (PDF) on 2011-07-25. Retrieved 2009-10-20.
  9. [9]
    "Media" (PDF).
  10. [10]
    Damian Garde (24 September 2015). "Novartis' top scientist is stepping down after 13 years, making way for a Harvard luminary". Fierce Biotech. Retrieved 13 December 2016.
Share this article:

This article uses material from the Wikipedia article Mark_Fishman, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.